Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand
- PMID: 24258360
- DOI: 10.1160/TH13-06-0479
Improvement of fibrin clot structure after factor VIII injection in haemophilia A patients treated on demand
Abstract
Patients with haemophilia A have seriously impaired thrombin generation due to an inherited deficiency of factor (F)VIII, making them form unstable fibrin clots that are unable to maintain haemostasis. Data on fibrin structure in haemophilia patients remain limited. Fibrin permeability, assessed by a flow measurement technique, was investigated in plasma from 20 patients with severe haemophilia A treated on demand, before and 30 minutes after FVIII injection. The results were correlated with concentrations of fibrinogen, FVIII and thrombin-activatable fibrinolysis inhibitor (TAFI), and global haemostatic markers: endogenous thrombin potential (ETP) and overall haemostatic potential (OHP). Fibrin structure was visualised using scanning electron microscopy (SEM). The permeability coefficient Ks decreased significantly after FVIII treatment. Ks correlated significantly with FVIII levels and dosage, and with ETP, OHP and levels of TAFI. SEM images revealed irregular, porous fibrin clots composed of thick and short fibers before FVIII treatment. The clots had recovered after FVIII replacement almost to levels in control samples, revealing compact fibrin with smaller intrinsic pores. To the best of our knowledge, this is the first description of fibrin porosity and structure before and after FVIII treatment of selected haemophilia patients. It seems that thrombin generation is the main determinant of fibrin structure in haemophilic plasma.
Keywords: FVIII; Fibrin clot structure; haemophilia A; scanning electron microscopy.
Similar articles
-
General haemostatic agents--fact or fiction?Pathophysiol Haemost Thromb. 2002;32 Suppl 1:33-6. doi: 10.1159/000057299. Pathophysiol Haemost Thromb. 2002. PMID: 12214145
-
Two global haemostatic assays as additional tools to monitor treatment in cases of haemophilia A.Thromb Haemost. 2012 Jul;108(1):21-31. doi: 10.1160/TH11-11-0811. Epub 2012 Apr 26. Thromb Haemost. 2012. PMID: 22534727
-
Stabilization of fibrin clots by activated prothrombin complex concentrate and tranexamic acid in FVIII inhibitor plasma.Haemophilia. 2011 Sep;17(5):e944-8. doi: 10.1111/j.1365-2516.2011.02491.x. Epub 2011 Mar 3. Haemophilia. 2011. PMID: 21371192
-
The role of thrombin in haemostasis.Blood Coagul Fibrinolysis. 2022 Apr 1;33(3):145-148. doi: 10.1097/MBC.0000000000001130. Epub 2022 Mar 2. Blood Coagul Fibrinolysis. 2022. PMID: 35239615 Review.
-
New assays for monitoring haemophilia treatment.Haemophilia. 2008 Jul;14 Suppl 3:83-92. doi: 10.1111/j.1365-2516.2008.01737.x. Haemophilia. 2008. PMID: 18510527 Review.
Cited by
-
Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII.J Thromb Haemost. 2022 Jul;20(7):1674-1683. doi: 10.1111/jth.15741. Epub 2022 May 22. J Thromb Haemost. 2022. PMID: 35466511 Free PMC article.
-
Thrombin-generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause.J Thromb Haemost. 2019 Sep;17(9):1478-1488. doi: 10.1111/jth.14529. Epub 2019 Jul 15. J Thromb Haemost. 2019. PMID: 31177606 Free PMC article.
-
Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges.Int J Mol Sci. 2021 Jun 28;22(13):6916. doi: 10.3390/ijms22136916. Int J Mol Sci. 2021. PMID: 34203139 Free PMC article. Review.
-
Automated Fiber Diameter and Porosity Measurements of Plasma Clots in Scanning Electron Microscopy Images.Biomolecules. 2021 Oct 18;11(10):1536. doi: 10.3390/biom11101536. Biomolecules. 2021. PMID: 34680169 Free PMC article.
-
Bleeding related to disturbed fibrinolysis.Br J Haematol. 2016 Oct;175(1):12-23. doi: 10.1111/bjh.14255. Epub 2016 Aug 1. Br J Haematol. 2016. PMID: 27477022 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical